Author

Bernard Moss

National Institutes of HealthORCID 0000-0002-2154-8564Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Assay:protein structure· 2 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Research Focus:protein structure prediction· 1

Frequent Co-Authors

Catherine A. CotteriD· 2 shared Maxinne A. Ignacio· 2 shared Patricia L. EarliD· 2 shared Ahmed A. Belghith· 1 shared Alec W. FreyniD· 1 shared Andrea Carfı́iD· 1 shared Apostolos G. GittisiD· 1 shared David N. GarbocziiD· 1 shared

Activity by Year

2024-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Catherine A. CotterORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Antibody Binding and Neutralizing Targets within the Predicted Structure of the Poxvirus Multiprotein Entry-Fusion Complex

Huibin Yu, Wolfgang Resch, Catherine A. Cotter, Wei Xiao, Tase Karamanolis, Ahmed A. Belghith, Maxinne A. Ignacio, Patricia L. Earl, Gary H. Cohen, Bernard Moss

The paper identifies two novel targets in the poxvirus EFC that induce cross-neutralizing antibodies and offers insights into immune evasion strategies.

bioRxiv · May 7, 2025 · PreprintMicrobiology

The 2.3 A Structure of A21, a Protein Component of the Conserved Poxvirus Entry-Fusion Complex

Ulrike S. Diesterbeck, Liya A. Muslinkina, Apostolos G. Gittis, Kavita Singh, Bernard Moss, David N. Garboczi

The paper determines the crystal structure of A21, a poxvirus EFC protein, revealing its conserved fold and interactions within the entry-fusion complex.

Journal of Molecular Biology · Mar 19, 2025Peer-reviewedMolecular Biology

Mpox mRNA-1769 Vaccine Inhibits Orthopoxvirus Replication at Intranasal, Intrarectal, and Cutaneous Sites of Inoculation

Catherine A. Cotter, Maxinne A. Ignacio, Jeffrey L. Americo, Patricia L. Earl, Eric M. Mucker, Tiffany R. Frey, Andrea Carfı́, Jay W. Hooper, Alec W. Freyn, Bernard Moss

The paper shows that an mRNA vaccine against mpox reduces virus replication at multiple inoculation sites and provides protection with a single dose, supported by antibody-mediated immunity.

npj Vaccines · Dec 24, 2024Peer-reviewedMicrobiology